foods including potatoes, bananas and vegetables all tested positive in 4% of the children. Pumpkin tested positive in one infant who had presented with rectal bleeding. Majority of the children had positive tests to multiple foods. Only 14% of the children had negative tests. The commonest gastrointestinal (GI) symptoms were abdominal pain (38%), constipation (36%), vomiting (14%), diarrhoea (11%), failure to thrive (9%) and colics (3%). Majority of the children had multiple GI symptoms. Eczema and cough were associated symptoms in 9% and 3% of the children respectively. Conclusions: The prevalence of food allergy as suggested by this study is high in Kenyan children and contributes signficantly towards gastrointestinal morbidity. While cow milk, egg and beef are the commonest allergens, the emerging allergy to local infant complementary foods is also significant. The high frequency of multiple allergens partly contributed to poor compliance in the exclusion rechallenge programme due to lack of options on alternative foods.
1. The predominant frequency of type IV of hypersensitivity reactions in children in response to the gluten antigen should be taken into account in diagnosis of food allergy. 2. In children diagnosed with gluten allergy the test for celiac disease should be performed.
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Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated after Simulated Orogastrointestinal Digestion Background: The aim of the study was to evaluate the allergenicity of one of the main allergens from cow milk, b-lactoglobulin (b-Lg) after being digested through a simulated orogastrointestinal digestion and to identify those peptides generated during the digestion process. Methods: The digestion was performed in 3 steps by using simulated oral, gastric and duodenal fluids. Digestibility of b-Lg was assessed by SDS-PAGE and RP-HPLC. IgE binding of native b-Lg and hydrolysates was evaluated by indirect ELISA, using the sera from 6 milk-allergic patients. The peptides produced during the orogastointestinal digestion, were identified by liquid chromatography tandem mass spectrometry analysis.
Results: Results showed that b-Lg was progressively degraded during the digestion. Intact b-Lg was observed after the gastric phase and in the first stages of the duodenal digestion. However, no residual b-Lg was observed at the end of the duodenal phase. Immunoassays showed that during the in vitro gastric and duodenal digestion immunoreactivity decreased progressively with an EC50 value increased 150 times at the end of the digestion. Among the products of digestion, 146 peptides were identified. No peptides were found in the oral phase. Forty five peptides were detected in the gastric phase, 71 in the duodenal, and 30 were common in both phases. Between those identified peptides, 4 of them with the sequences LIVTQTMK, GLDIQK, IDALNENK, and VLVLDTDYK had been previously described as epitopes of b-Lg.
Conclusions: b-Lg is progressively degraded during the digestion process. Similarly, b-Lg allergenicity is reduced through the simulated digestion with a severe reduction at the end of the duodenal stage. From the digestion products, 147 peptides have been identified. Studies are underway to evaluate the ability to cross the intestinal barrier and to bind to human-IgE of the most relevant identified peptides. Results: Descriptive statistics indicated that 259 of the sample reported giving their child one or more of the anti-inflammatory medication prescribed. Of these, 69 (27%) were diagnosed as NA, operationalized as whether a parent reported giving the child anti-inflammatory medication "less than prescribed by their physician." During the 4 weeks prior to completing the survey, 43.0% were having symptoms daily and 39.4% were using albuterol MDI daily. In this cross-sectional data set, items intended to relate risk factors to NA were examined using chi square (x 2 ). Parents who claimed that their child receive less anti-inflammatory medication than prescribed, were more likely to report: 1) symptoms from emotional states: crying x 2 (df ¼ 2) ¼ 8.643 P ¼ 0.013; frustration x 2 (df ¼ 2) 6.202 P ¼ 0.045; anger x 2 (df ¼ 2) ¼ 11.029 P ¼ 0.0042); Parent more likely to see child as anxious or a worrier x 2 (df ¼ 2) ¼ 6.527 P ¼ 0.038; 2) Child's Quality of Life (QoL): is more likely to be effected at school x 2 (df ¼ 2) ¼ 12.963 P ¼ 0.002; and interfere with family activities x 2 Abstracts WAO Journal February 2012 S158 Ó 2012 World Allergy Organization
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